Live News Categoriesmarket

QNTM.O (QNTM.O) News

Follow QNTM.O (QNTM.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol QNTM.O Asset market Sector Markets 90 days 1 Updated Oct 06, 2026, 10:06 AM UTC Open live news feed

M Quantum BioPharma signs PPD contract for Phase 2 MS trial Quantum BioPharma has signed a study start-up agreement with Thermo Fisher’s PPD clinical research unit to implement a Phase 2 trial of Lucid-MS for progressive multiple sclerosis. EQUITY | Oct 06, 2026, 10:06 AM UTC